Exact Sciences Corp (EXAS) Misses Q1 Expectations
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Exact Sciences Corp (NASDAQ: EXAS) reported Q1 EPS of ($0.23), $0.04 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $294 thousand versus the consensus estimate of $600 thousand.
For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lumentum shares rise on analyst upgrades, AI demand outlook
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
